PITUITARY ADENYLATE CYCLASE-ACTIVATING PEPTIDE (PACAP) MIMICS THE ACTIONS OF VASOACTIVE-INTESTINAL-PEPTIDE (VIP) ON GASTRIC CHIEF CELLS

被引：0
|
作者：
RAUFMAN, JP [1 ]
SINGH, L [1 ]
机构：
[1] SUNY HLTH SCI CTR,DEPT MED,BROOKLYN,NY
来源：
CLINICAL RESEARCH | 1992年 / 40卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A262 / A262
页数：1
相关论文
共 50 条
  • [1] PITUITARY ADENYLATE CYCLASE-ACTIVATING PEPTIDE (PACAP), A NEW VASOACTIVE-INTESTINAL-PEPTIDE (VIP)-LIKE PEPTIDE IN THE RESPIRATORY-TRACT
    UDDMAN, R
    LUTS, A
    ARIMURA, A
    SUNDLER, F
    CELL AND TISSUE RESEARCH, 1991, 265 (01) : 197 - 201
  • [2] STIMULATORY ACTIONS OF PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP) AND VASOACTIVE-INTESTINAL-PEPTIDE (VIP) ON PEPTIDE YY RELEASE IN THE DOG
    ZHANG, T
    MOCHIZUKI, T
    YANAIHARA, N
    GOMEZ, G
    THOMPSON, JC
    GREELEY, G
    REGULATORY PEPTIDES, 1992, 40 (02) : 286 - 286
  • [3] Anorexigenic actions of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) on food intake in the goldfish, Carassius auratus
    Matsuda, K
    Maruyama, K
    Nakamachi, T
    Miura, T
    Uchiyama, M
    Shioda, S
    REGULATORY PEPTIDES, 2005, 130 (03) : 170 - 170
  • [4] RECEPTORS FOR PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE - COMPARISON WITH VASOACTIVE-INTESTINAL-PEPTIDE RECEPTORS
    ARIMURA, A
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1992, 3 (08): : 288 - 294
  • [5] VASOACTIVE-INTESTINAL-PEPTIDE, BUT NOT PITUITARY ADENYLATE CYCLASE-ACTIVATING PEPTIDE, MODULATES THE RESPONSIVENESS OF THE GONADOTROPH TO LHRH IN MAN
    HAMMOND, PJ
    TALBOT, K
    CHAPMAN, R
    GHATEI, MA
    BLOOM, SR
    JOURNAL OF ENDOCRINOLOGY, 1993, 137 (03) : 529 - 532
  • [6] Central pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) decrease the baroreflex sensitivity in trout
    Lancien, Frederic
    Mimassi, Nagi
    Conlon, J. Michael
    Le Mevel, Jean-Claude
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2011, 171 (02) : 245 - 251
  • [7] Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunity
    Ganea, D
    Delgado, M
    CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 2002, 13 (03) : 229 - 237
  • [8] Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP-27, but not PACAP-38) degradation by the neutral endopeptidase EC 3.4.24.11
    Gourlet, P
    Vandermeers, A
    Robberecht, P
    DeschodtLanckman, M
    BIOCHEMICAL PHARMACOLOGY, 1997, 54 (04) : 509 - 515
  • [9] Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) in humans with multiple sclerosis
    Baranowska-Bik, Agnieszka
    Kochanowski, Jan
    Uchman, Dorota
    Wolinska-Witort, Ewa
    Kalisz, Malgorzata
    Martynska, Lidia
    Baranowska, Boguslawa
    Bik, Wojciech
    JOURNAL OF NEUROIMMUNOLOGY, 2013, 263 (1-2) : 159 - 161
  • [10] Ventilatory and cardiovascular actions of centrally and peripherally administered trout pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) in the unanaesthetized trout
    Le Mevel, J. -C.
    Lancien, F.
    Mimassi, N.
    Conlon, J. M.
    JOURNAL OF EXPERIMENTAL BIOLOGY, 2009, 212 (23): : 3919 - 3927
12345